Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial

Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial

Abstract Background Bariatric surgery has adverse effects on the muscular-skeletal system with loss of bone mass and muscle mass and an increase in the risk of fracture. Zoledronic acid is widely used in osteoporosis and prevents bone loss and fracture. Bisphosphonates may also have positive effects...

Full description

Bibliographic Details
Main Authors: Søren Gam, Bibi Gram, Claus Bogh Juhl, Anne Pernille Hermann, Stinus Gadegaard Hansen
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Trials
Subjects:
Bariatric surgery
Gastric bypass
Sleeve gastrectomy
Bone loss
Muscle loss
Zoledronic Acid
Online Access:https://doi.org/10.1186/s13063-022-06766-z

Internet

https://doi.org/10.1186/s13063-022-06766-z

Similar Items